日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial

雌激素受体阳性/人表皮生长因子受体2阴性晚期乳腺癌患者的患者报告结局和定性访谈:来自III期EMBER-3试验的结果

Curigliano, G; O'Shaughnessy, J; Bidard, F-C; Casalnuovo, M L; Kim, S-B; Tokunaga, E; Aftimos, P; Saura, C; Carey, L A; Okera, M; Melo, E; Zagouri, F; Magallanes-Maciel, M; Karadurmus, N; Bahadur, S; Speck, R M; Wang, X A; Pradhan, K; Macey, J; Kitchen, H; Fairhurst, S; Miller, J; Jhaveri, K L; Harbeck, N

First Case of Neuroblastoma-Like Somatic-Type Malignancy Arising in the Teratomatous Component of a Mixed Non-Seminomatous Testicular Germ Cell Tumor in an Adult

成人混合性非精原细胞性睾丸生殖细胞肿瘤畸胎瘤成分中发生的首例神经母细胞瘤样体细胞型恶性肿瘤

Ziade, Karl; Kotaich, Jana; Assaf, Serge; Aftimos, Valerie; Ziade, Adib

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

持续补充功能失调的 CD8 T 细胞轴与晚期乳腺癌化疗免疫疗法的疗效相关

Metoikidou Christina, Karnaukhov Vadim, Boeckx Bram, Timperi Eleonora, Bonté Pierre-Emmanuel, Wang Ling, Espenel Marion, Albaud Benoit, Loirat Delphine, Wang Xiaoxiao, Sotiriou Christos, Aftimos Philippe, Punie Kevin, Wildiers Hans, Labroska Viktorija, Wang Ming-Wei, Waterfall Joshua J, Piccart-Gebhart Martine, Mora Thierry, Walczak Aleksandra, Lantz Olivier, Buisseret Laurence, Lambrechts Diether, Amigorena Sebastian, Romano Emanuela

Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population

晚期实体瘤人群综合基因组分析的经济评价

van Schaik, Lucas F; Maes, Brigitte; Volders, Pieter-Jan; Froyen, Guy; Aftimos, Philippe; de Azambuja, Evandro; Blommestein, Hedwig M; van Harten, Wim H; Retèl, Valesca P

Development and implementation of novel liquid biopsy NGS panels via the OncNGS precommercial procurement (PCP) initiative

通过OncNGS商业化前采购(PCP)计划开发和实施新型液体活检NGS检测板

Raicevic Toungouz, G; Alessandrello, R; Giacomini, P; Kamal, M; Gausachs, M; Mazzarella, L; Sujobert, P; Frigè, G; Alay, A; Planchon, J M; Blau, O; Mias Carballal, M R; Antoine-Poirel, H; Nadal, E; Bullinger, L; Hebrant, A; Servant, N; D'Haene, N; Aftimos, P; Silkenstedt, E; Michalík, A; Dupain, C; Delcourt, T; Huet, S; Van Campenhout, C; Cordero, D; Castellano Garcia, J M; Codony, C; Krol, A; Gonzalo, J; Van Damme, N; Delnord, M; Carbone, R; Trapani, V; Van Garsse, S; Van Den Bulcke, M

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge

HR阳性/HER2阴性早期乳腺癌辅助CDK4/6抑制剂治疗期间或之后复发的管理:一项新出现的挑战

Gerosa, R; Gentile, G; Arecco, L; Dauccia, C; Nannini, S; Lobo-Martins, S; Agostinetto, E; Lambertini, M; Santoro, A; Aftimos, P; Piccart-Gebhart, M; de Azambuja, E

A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer

面向晚期癌症患者的全国性综合基因组分析和分子肿瘤委员会平台

Volders, Pieter-Jan; Aftimos, Philippe; Dedeurwaerdere, Franceska; Martens, Geert; Canon, Jean-Luc; Beniuga, Gabriela; Froyen, Guy; Van Huysse, Jacques; De Pauw, Rebecca; Prenen, Hans; Lambin, Suzan; Decoster, Lore; Vaeyens, Freya; Rottey, Sylvie; Van Dam, Pieter-Jan; Decoster, Lynn; Rutten, Annemie; Schreuer, Max; Loontiens, Siebe; Van der Meulen, Joni; Mebis, Jeroen; Cuppens, Kristof; Tejpar, Sabine; Vanden Bempt, Isabelle; De Grève, Jacques; Schröder, David; van Marcke, Cédric; Van Den Bulcke, Marc; de Azambuja, Evandro; Punie, Kevin; Maes, Brigitte

Imlunestrant, an oral selective estrogen receptor degrader, in combination with HER2 directed therapy, with or without abemaciclib, in ER-positive, HER2-positive advanced breast cancer: results from the phase 1a/1b EMBER study

伊姆鲁司群(一种口服选择性雌激素受体降解剂)联合HER2靶向治疗,无论是否联合阿贝西利,用于治疗ER阳性、HER2阳性晚期乳腺癌:来自EMBER 1a/1b期研究的结果

Bhave, Manali; Jhaveri, Komal L; Kaufman, Peter A; Aftimos, Philippe; Lombard, Janine; Giridhar, Karthik V; Im, Seock-Ah; Ma, Cynthia X; Lee, Kuo-Ting; Kim, Sung-Bae; Sohn, Joohyuk; Li, Yujia; Yuen, Eunice; Estrem, Shawn T; Nguyen, Bastien; Makena, Monish Ram; Ismail-Khan, Roohi; Beeram, Muralidhar

Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma: case study and literature review - an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need

奥拉帕尼治疗BRIP1突变转移性高级别多形性肉瘤实现完全缓解:病例研究和文献综述——基于基因组分析的肿瘤治疗案例,针对一种临床需求未被满足的癌症类型

Thooft, Alexander D J; Joris, Sofie; Jacobs, Celine; Creytens, David; Rottey, Sylvie; Maes, Brigitte; Aftimos, Philippe; Lapeire, Lore

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study

伊姆伦司群(一种口服选择性雌激素受体降解剂)单药治疗及联合靶向治疗在雌激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌中的疗效:EMBER Ia/Ib期研究

Jhaveri, Komal L; Lim, Elgene; Jeselsohn, Rinath; Ma, Cynthia X; Hamilton, Erika P; Osborne, Cynthia; Bhave, Manali; Kaufman, Peter A; Beck, J Thaddeus; Manso Sanchez, Luis; Parajuli, Ritesh; Wang, Hwei-Chung; Tao, Jessica J; Im, Seock-Ah; Harnden, Kathleen; Yonemori, Kan; Dhakal, Ajay; Neven, Patrick; Aftimos, Philippe; Pierga, Jean-Yves; Lu, Yen-Shen; Larson, Timothy; Jerez, Yolanda; Sideras, Kostandinos; Sohn, Joohyuk; Kim, Sung-Bae; Saura, Cristina; Bardia, Aditya; Sammons, Sarah L; Bacchion, Francesca; Li, Yujia; Yuen, Eunice; Estrem, Shawn T; Rodrik-Outmezguine, Vanessa; Nguyen, Bastien; Ismail-Khan, Roohi; Smyth, Lillian; Beeram, Muralidhar